CORT logo

CORT

Corcept Therapeutics Incorporated

$69.72
+$0.14(+0.19%)
43
Overall
20
Value
60
Tech
50
Quality
Market Cap
$7.33B
Volume
397.82K
52W Range
$33.34 - $117.33
Target Price
$134.50
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$50.3M$81.3M$159.2M$251.2M$306.5M$353.9M$366.0M$401.9M$482.4M$675.0M
Total Revenue
$50.3M$81.3M$159.2M$251.2M$306.5M$353.9M$366.0M$401.9M$482.4M$675.0M
COST OF GOODS SOLD
Cost of Revenue
$-1.4M$-2.1M$-3.6M$-5.2M$5.5M$5.6M$5.3M$5.4M$6.5M$10.9M
GROSS PROFIT
Gross Profit
$48.9M$79.3M$155.6M$246.0M$301.0M$348.3M$360.7M$396.5M$475.9M$664.2M
OPERATING EXPENSES
Operating Expenses
$52.4M$69.1M$102.8M$156.5M$189.4M$220.1M$236.2M$283.8M$368.6M$527.2M
Research & Development
$15.4M$23.8M$40.4M$75.2M$89.0M$114.8M$113.9M$131.0M$184.4M$246.9M
Research Expense
$15.4M$23.8M$40.4M$75.2M$89.0M$114.8M$113.9M$131.0M$184.4M$246.9M
Selling, General & Administrative
$36.9M$45.2M$62.4M$81.3M$100.4M$105.3M$122.4M$152.8M$184.3M$280.3M
Selling & Marketing Expenses
$36.9M$45.2M$62.4M$81.3M------------
General & Administrative Expenses
$-678.0K$-900.0K$-1.1M$-1.3M$100.4M$105.3M$122.4M$152.8M$184.3M$280.3M
Salaries & Wages
$-6.0M$-7.1M$-13.4M$-23.8M$29.4M$33.8M$43.2M------
Other Operating Expenses
$-169.0K$-152.0K$-20.7M$-752.0K$-1.0M$-1.3M$-1.7M------
OPERATING INCOME
Operating income
$-3.4M$10.2M$52.9M$89.5M$111.6M$128.2M$124.5M$112.6M$107.3M$137.0M
EBITDA
$-6.2M$8.2M$52.9M$92.4M$118.8M$130.4M$128.0M$119.6M$126.9M$162.8M
NON-OPERATING ITEMS
Interest Income Operating
------$2.7M------------
Net Non-Operating Interest Income/Expense
$-3.0M$-2.0M$-49.0K--------$-3.6M$-17.3M--
Gain on Sale of Securities
----$-49.0K--------------
Other Income/Expense
--$2.0M$-15.7M$-29.3M$-28.1M$-26.5M$-31.4M$-3.6M$-17.3M$-24.5M
Other Special Charges
--------------$3.6M$17.3M$24.5M
SPECIAL ITEMS
Restructring And Mn A Income
$-2.8M$-1.9M$-500.0K--------------
Special Income Charges
$2.8M$1.9M$500.0K$2.7M------$14.0M----
PRE-TAX INCOME
EBIT
$-6.4M$8.1M$52.8M$92.2M$116.7M$128.2M$124.5M$116.2M$124.6M$161.5M
Pre-Tax Income
$-6.4M$8.1M$52.8M$92.2M$116.7M$131.6M$125.0M$116.2M$124.6M$161.5M
INCOME TAX
Tax Provision
----$-76.3M$16.7M$22.5M$25.6M$12.5M$14.8M$18.4M$20.3M
NET INCOME
Net Income
$-6.4M$8.1M$129.1M$75.4M$94.2M$106.0M$112.5M$101.4M$106.1M$141.2M
Net Income (Continuing Operations)
$-6.4M$8.1M$129.1M$75.4M$94.2M$106.0M$112.5M$101.4M$106.1M$141.2M
Net Income (Discontinued Operations)
$-6.4M$8.1M$129.1M$75.4M$94.2M$106.0M$112.5M$101.4M$106.1M$141.2M
Net Income (Common Stockholders)
$-6.4M$8.1M$129.1M$75.4M$89.1M$106.0M$112.5M$101.3M$105.5M$139.7M
Normalized Income
------------------$159.9M
TOTALS
Total Expenses
$51.0M$67.0M$99.2M$151.3M$194.9M$225.7M$241.5M$289.2M$375.1M$538.1M
SHARE & EPS DATA
Average Shares Outstanding
$106.9M$110.6M$113.5M$115.3M$114.3M$115.4M$115.7M$106.8M$103.6M$103.2M
Average Shares Outstanding (Diluted)
$106.9M$116.1M$124.5M$126.7M$122.6M$124.2M$126.0M$116.0M$111.7M$113.5M
Shares Outstanding
$109.7M$112.9M$114.8M$114.7M$114.6M$117.3M$105.4M$107.9M$103.5M$105.5M
Basic EPS
--$0.07$1.14$0.65$0.82$0.92$0.97$0.95$1.02$1.35
Basic EPS (Continuing Operations)
--------$0.82$0.92$0.97$0.95$1.02$1.35
Diluted EPS
$-0.06$0.07$1.04$0.60$0.77$0.85$0.89$0.87$0.94$1.23
Diluted EPS (Continuing Operations)
--------$0.77$0.85$0.89$0.87$0.94$1.23
OTHER METRICS
Accrued Preferred Stock Dividends
------------$-112.5M$-101.3M$-105.5M$-139.7M
Acquired In Process Rn D
------$2.7M------------
Other Gand A
$-678.0K$-900.0K$-1.1M$-1.3M$100.4M$105.3M$122.4M$152.8M$184.3M$280.3M
Other Write Off
----$-15.7M$-29.3M$-28.1M$-26.5M$-31.4M------
Otherunder Preferred Stock Dividend
------------$-112.5M$-101.3M$-105.5M$-139.7M
Preferred Stock Dividends
------------$-112.5M$-101.3M$-105.5M$-139.7M
Rent And Landing Fees
$-678.0K$-900.0K$-1.1M$-1.3M------------
Selling Expense
$36.9M$45.2M$62.4M$81.3M------------
Restruct
$-2.8M$-1.9M$-500.0K--------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CORT$69.72+0.2%397.82K
3
4
5
6

Get Corcept Therapeutics Incorporated Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.